Profile data is unavailable for this security.
About the company
JCR Pharmaceuticals Co., Ltd. is a Japan-based company primarily engaged in the pharmaceutical business, as well as the medical and research equipment business. The Company operates in two segments. The Pharmaceutical segment engages in the research, production, purchase and sale of medical drugs and pharmaceutical raw materials. The Medical and Research Equipment segment engages in the purchase and sale of the medical and research equipment.
- Revenue in JPY (TTM)33.07bn
- Net income in JPY-4.76bn
- Incorporated1975
- Employees987.00
- LocationJCR Pharmaceuticals Co Ltd3-19, Kasuga-choASHIYA-SHI 659-0021JapanJPN
- Phone+81 797328591
- Websitehttps://www.jcrpharm.co.jp/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cuorips Inc | 175.21m | -644.34m | 49.58bn | 56.00 | -- | 8.95 | -- | 282.97 | -80.64 | -80.64 | 21.89 | 682.90 | 0.0294 | 0.299 | 2.19 | 3,128,661.00 | -10.82 | -- | -11.15 | -- | 96.03 | -- | -368.32 | -- | 28.65 | -17.49 | 0.00 | -- | 658.40 | -- | -1.92 | -- | -- | -- |
| ASKA Pharmaceutical Holdings Co Ltd | 64.14bn | 5.10bn | 69.61bn | 1.63k | 13.45 | 1.05 | 9.47 | 1.09 | 179.94 | 179.94 | 2,262.57 | 2,302.59 | 0.6706 | 1.40 | 4.18 | 39,300,860.00 | 5.33 | 5.50 | 7.26 | 7.07 | 48.86 | 47.56 | 7.95 | 7.98 | 1.39 | -- | 0.1361 | 16.60 | 2.06 | 4.07 | -32.39 | 51.04 | 9.49 | 31.48 |
| Nxera Pharma Co Ltd | 30.87bn | -2.32bn | 78.55bn | 374.00 | -- | 1.16 | 44.48 | 2.54 | -25.83 | -25.83 | 343.68 | 746.05 | 0.2072 | 1.48 | 6.96 | 82,534,760.00 | -1.56 | -1.71 | -1.72 | -1.85 | 73.95 | 84.07 | -7.51 | -10.93 | 3.11 | -- | 0.497 | -- | 125.87 | 24.28 | 32.74 | -- | 40.57 | -- |
| JCR Pharmaceuticals Co Ltd | 33.07bn | -4.76bn | 87.41bn | 987.00 | -- | 1.75 | -- | 2.64 | -38.86 | -38.86 | 267.09 | 386.12 | 0.3194 | 0.5309 | 2.43 | 33,507,600.00 | -4.54 | 5.86 | -7.10 | 9.33 | 65.73 | 73.83 | -14.20 | 13.60 | 0.666 | -26.06 | 0.4466 | 45.13 | -22.86 | 5.94 | -186.42 | -- | 15.37 | 20.11 |
| Kyorin Pharmaceutical Co Ltd | 130.09bn | 9.09bn | 89.98bn | 2.00k | 9.49 | 0.6327 | 6.57 | 0.6917 | 158.16 | 158.16 | 2,264.40 | 2,372.28 | 0.7008 | 1.18 | 2.78 | 65,108,610.00 | 4.89 | 3.34 | 6.25 | 4.16 | 45.77 | 45.89 | 6.98 | 5.11 | 2.01 | -- | 0.1727 | 57.34 | 8.83 | 3.41 | 70.73 | 8.12 | 14.36 | -7.06 |
| Katakura Industries Co Ltd | 40.12bn | 3.92bn | 90.50bn | 941.00 | 21.32 | 0.974 | 13.01 | 2.26 | 120.54 | 120.54 | 1,233.12 | 2,638.59 | 0.2885 | 2.32 | 4.76 | 42,634,430.00 | 2.97 | 2.60 | 3.66 | 3.57 | 37.01 | 37.98 | 10.29 | 9.44 | 2.55 | -- | 0.0947 | 23.42 | -1.37 | -2.19 | 15.73 | 15.27 | -7.22 | 33.03 |
| Mochida Pharmaceutical Co Ltd | 105.16bn | 5.69bn | 109.53bn | 1.51k | 18.77 | 0.8165 | 12.70 | 1.04 | 160.36 | 160.36 | 2,966.32 | 3,686.67 | 0.6595 | 1.62 | 3.16 | 69,734,090.00 | 3.57 | 4.50 | 4.24 | 5.44 | 51.15 | 52.49 | 5.41 | 6.87 | 3.47 | 40.43 | 0.0026 | 43.01 | 2.21 | 0.6516 | 25.03 | 4.34 | 1.98 | 0.00 |
| Zeria Pharmaceutical Co Ltd | 87.31bn | 9.94bn | 110.70bn | 1.75k | 9.25 | 1.03 | 6.32 | 1.27 | 225.42 | 225.42 | 1,980.76 | 2,031.33 | 0.5638 | 1.51 | 3.70 | 50,006,380.00 | 6.44 | 4.67 | 9.95 | 7.47 | 73.25 | 72.17 | 11.42 | 9.02 | 0.9752 | -- | 0.3209 | 28.75 | 15.30 | 7.64 | 28.52 | 27.71 | 16.51 | 6.69 |
Data as of Jul 18 2025. Currency figures normalised to JCR Pharmaceuticals Co Ltd's reporting currency: Japanese Yen JPY
10.88%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Nomura Asset Management Co., Ltd.as of 14 Feb 2025 | 5.53m | 4.26% |
| The Vanguard Group, Inc.as of 02 Jul 2025 | 2.57m | 1.98% |
| Norges Bank Investment Managementas of 31 Dec 2024 | 1.87m | 1.44% |
| Nikko Asset Management Co., Ltd.as of 04 Jul 2025 | 985.60k | 0.76% |
| Daiwa Asset Management Co. Ltd.as of 30 May 2025 | 954.80k | 0.74% |
| PineBridge Investments Japan Co., Ltd.as of 31 Dec 2024 | 581.90k | 0.45% |
| Tokio Marine Asset Management Co., Ltd.as of 20 Jun 2024 | 555.60k | 0.43% |
| Mitsubishi UFJ Asset Management Co., Ltd.as of 03 Jul 2025 | 420.20k | 0.32% |
| Sumitomo Mitsui DS Asset Management Co., Ltd.as of 03 Jul 2025 | 365.10k | 0.28% |
| Aviva Investors Global Services Ltd.as of 30 May 2025 | 284.40k | 0.22% |
More ▼
Data from 31 Dec 2024 - 30 Jun 2025Source: FactSet Research Systems Inc.
